Chernett Jorey

10% Owner Chernett Jorey buys 18,000 shares of TOI at $5.02; fifth consecutive buy in 7 weeks with 30-day returns averaging +29%.

Chernett Jorey, a 10% owner, purchased 18,000 shares at $5.02 on 2026-06-23, extending a recent pattern of aggressive accumulation at this ticker. Over the prior 7 weeks (2026-04-09 through 2026-06-04), Jorey executed 4 prior purchases at TOI, each yielding positive 30-day returns: +29.0%, +29.9%, +28.6%, and +29.2%. The current acquisition follows the same cadence. At the same-ticker level, these five cumulative buys demonstrate sustained conviction, and the consistent 30-day performance suggests market receptivity. However, the company remains unprofitable with net income of $-2.5M in the latest quarter, despite 27.8% annual revenue growth—a risk factor for a major holder accumulating shares at current levels. The stock trades at $5.27 today, 5.6% below its 52-week high of $5.58, and has gained 14.8% over 30 days; whether this momentum persists beyond the typical 30-day window is unknown, as no 90-day outcomes are yet measurable for any of these recent trades.

10% Owner Chernett Jorey purchases 12,000 TOI shares at $4.75; prior 5 trades at ticker all posted positive 90d returns.

Chernett Jorey, holding 10.58M shares post-transaction, purchased 12,000 shares at $4.75 on 2026-06-04 for $57.0K. His prior 5 trades at TOI showed consistent positive 90-day returns: 16.5%, 17.0%, 15.9%, 29.0%, and 60.1%, with all five purchases gaining value over the 90-day window. His cross-ticker buy track record spans 20 prior transactions with average 90d return +42.8% and a 90d win rate of 90.00%. The current stock price of $4.88 sits 0.4% below the 52-week high of $4.90, having risen 28.4% over 30 days and 75.5% over 90 days. Despite this momentum, the company reported net income of $-2.5M over its most recent full fiscal year and remains unprofitable, though annual revenue growth reached +27.8%.

10% Owner Chernett Jorey purchases 38,500 shares at $4.07 avg; stock +18.2% in 30d, +60.0% in 90d

Chernett Jorey, a 10% owner, executed 2 separate purchases totaling 38,500 shares for $156,595.00 at a blended average price of $4.07 on 2026-05-19 and 2026-05-20, increasing his holdings from 10.53M to 10.57M shares. The timing of this purchase aligns with a notable price recovery: the stock has risen 18.2% over 30 days and 60.0% over 90 days, and is currently trading at $4.16, only 14.8% below its 52-week high of $4.88. His 5 prior purchases at this ticker all showed positive 90-day returns (+3.2% to +38.5%), establishing a consistent pattern of prior trades that eventually gained. The company reported quarterly revenue of $147.4M with annual growth of +27.8%, though it remains unprofitable with $-2.5M net income in the latest quarter. This buy by a major shareholder during a period of stock appreciation warrants observation given his track record at this ticker.

10% Owner Chernett Jorey buys 100,000 shares of STIM at $1.17; stock down -75.5% from 52-week high, all 5 prior STIM trades unprofitable at 90-day mark

Chernett Jorey, a 10% owner, purchased 100,000 shares at $1.17 on 2026-05-19, increasing holdings from 10,453,988 to 10,553,988 shares. The stock has declined -24.7% over 30 days and trades -75.5% below its 52-week high of $4.85. More notably, Jorey's five prior purchases at STIM produced uniformly negative 90-day outcomes, with a 0 of 5 well-timed rate at the 90-day mark, suggesting a pattern of unfavorable timing at this specific ticker despite his cross-ticker track record averaging +28.6% over 90 days across 20 prior buys. The company is unprofitable (net income of $-10,790,000.00 for the latest quarter) while showing strong annual revenue growth of +99.2%, creating mixed fundamental signals that may explain continued accumulation by a significant shareholder in a depressed stock.

10% owner Chernett Jorey purchased 30,000 shares of TOI at $4.09 on 2026-05-19; 5 of 5 prior TOI buys showed positive 90d returns

Chernett Jorey, a 10% owner, purchased 30,000 shares at $4.09, bringing holdings to 10,529,358 shares and raising his stake slightly by 30,000 shares. This represents his sixth purchase at TOI over a concentrated period; across his prior five TOI trades, all five generated positive 90-day returns (ranging from +22.4% to +38.5%), indicating a pattern of consistent timing accuracy at this ticker. The company carries meaningful headwinds—it is unprofitable (net income of $-2,492,000 on revenue of $147,441,000) and the stock trades 14.8% below its 52-week high—yet the insider continues to accumulate. The 30-day momentum is strong at +18.2%, and the 90-day move of +60.0% suggests near-term strength, but the transaction's significance derives from whether the insider's historically well-timed pattern at TOI persists and whether an unprofitable but revenue-growing business ($147,441,000 latest quarter, +27.8% annual growth) can narrow losses in the medium term.

10% owner Chernett Jorey buys 475,000 shares at $1.34; stock now at $1.19, down 24.7% in 30 days; prior STIM buys 0 of 5 well-timed at 90d mark.

Chernett Jorey, a 10% owner, purchased 475,000 shares of Neuronetics at $1.34 on 2026-05-12, increasing holdings by 4.8% to 10.45M shares. However, the stock has declined to $1.19 (down 24.7% over 30 days and 75.5% from its 52-week high of $4.85), eroding the transaction value. More significantly, Jorey's prior five purchases at STIM show a consistent pattern of poor timing: none of the five earlier buys delivered positive 90-day returns, with losses ranging from -5.6% to -25.3% at the 90-day mark. While Jorey's cross-ticker track record shows a 60% 90-day win rate with +28.6% average return, this insider's execution at STIM has been markedly unsuccessful. The company remains unprofitable (net income $-10.8M in the latest quarter) despite 99.2% annual revenue growth, adding fundamental concern to the timing pattern.

10% owner Chernett Jorey buys 200,000 shares in 2 transactions for $309,000.00 as STIM trades -65.9% from 52-week high

Chernett Jorey, a 10% owner, executed 2 separate purchases totaling 200,000 shares for $309,000.00 at an average blended price of $1.54 on April 20-21, 2026. The timing coincides with a steep drawdown: the stock trades at $1.59 currently, down 65.9% from its 52-week high and off 27.7% over the past 90 days. Neuronetics is unprofitable (net income $-9.0M in the latest period) but growing revenue sharply (99.2% annual growth), suggesting the share price decline reflects near-term losses rather than growth concerns. Jorey's cross-ticker track record shows his prior 20 open-market buys averaged -1.5% returns over 30 days, and at this ticker specifically, 4 of his 5 prior trades remain unmeasurable in outcome; his one dated 2026-03-20 achieved a modest +0.7% 30-day return. This filing adds 200,000 shares (2.0% increase) to his position, now 9.98M shares post-transaction, representing further accumulation during an extended decline.

10% owner Chernett Jorey buys 40,000 AIRS shares at $2.54; stock down 77.3% YTD, company posted $-9.5M loss on $35.0M revenue.

Chernett Jorey, a 10% owner, purchased 40,000 shares at $2.54 on 2026-04-17, adding to recent buying activity at this ticker (4 additional buys in the prior two weeks). The current price of $2.64 reflects minimal movement since purchase, while the stock remains 77.3% below its 52-week high of $11.65. Fundamentally, Airsculpt is in significant distress: the company posted a net loss of $-9.5M on revenue of $35.0M in the latest quarter, with annual revenue declining 15.8% year-over-year. His cross-ticker track record shows a modest -0.4% average 30-day return across 20 prior buys, providing no strong evidence of timing acumen. The rapid succession of open-market purchases at this ticker—five transactions in under a month—occurs against a backdrop of operational losses and declining top-line growth, warranting attention to whether these acquisitions reflect attempts to maintain voting control amid deteriorating fundamentals.

10% owner Chernett Jorey bought 20,000 shares of AIRS at $2.60 on 2026-04-14; stock down -76.0% from 52-week high despite recent 25.7% 90-day gain.

Chernett Jorey, a 10% owner, purchased 20,000 shares at $2.60 on 2026-04-14, bringing holdings to 7,013,761 shares. This marks the fifth consecutive buy at AIRS within a 27-day window (2026-03-19 through 2026-04-14), suggesting sustained accumulation during a period of significant stock weakness. The company is unprofitable with a -$9,512,000.00 net income on $34,993,000.00 quarterly revenue and -15.8% annual revenue growth, establishing a backdrop of operational stress. While the stock has recovered +25.7% over 90 days from deeper lows, it remains -76.0% from its 52-week high of $11.65, indicating substantial lost value. The repeated buying pattern during weakness and alongside negative fundamentals warrants scrutiny of whether this reflects a holder protecting a large position or a counter-trend accumulation bet.

10% owner Chernett Jorey buys 20,000 TOI shares at $3.10 (4th trade in 10 days); stock up 16.2% in 30 days, down 6.5% in 90 days from purchase

Chernett Jorey, a 10% shareholder, purchased 20,000 shares at $3.10 on 2026-04-09, extending a cluster of five buy transactions over a 20-day period (2026-03-17 through 2026-04-09). The company is unprofitable (net income $-16,504,000 in the latest quarter) despite strong top-line growth of +27.8% year-over-year and a market cap of $326.2M. The stock has recovered 16.2% in the 30 days since this purchase but remains down 6.5% over 90 days, trading at $3.30 against a 52-week high of $4.75. The rapid succession of buys during a period of volatility and the 10% ownership stake warrant monitoring for any public announcements or strategic context that might illuminate the timing and conviction behind these purchases.